Friday, March 18, 2016

BRIEF-Eagle Pharmaceuticals says FDA rejects company's blood thinner

* Eagle Pharmaceuticals receives complete response letter

from FDA on Kangio (RTU Bivalirudin) application

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)